<?xml version='1.0' encoding='utf-8'?>
<document id="28280890"><sentence text="Utilization of chi-square statistics for screening adverse drug-drug interactions in spontaneous reporting systems." /><sentence text="We proposed a statistical criterion to detect drug-drug interactions causing adverse drug reactions in spontaneous reporting systems" /><sentence text="" /><sentence text="The used criterion quantitatively measures the discrepancy between the observed and expected number of adverse events via chi-square statistics" /><sentence text=" We compared the performance of our method with that of Norén et al" /><sentence text=" (Stat Med 2008; 27 (16): 3057-3070) through a simulation study" /><sentence text="" /><sentence text="When the number of events for a combination of two drugs was equal to or lower than two, the false positive rate for our method ranged from 0" /><sentence text="01 to 0" /><sentence text="08, whereas the rate for Norén's method ranged from 0" /><sentence text="01 to 0" /><sentence text="06" /><sentence text=" The sensitivity for our method ranged from 0" /><sentence text="09 to 0" /><sentence text="29, whereas the sensitivity for Norén's method ranged from 0" /><sentence text="03 to 0" /><sentence text="24" /><sentence text=" The area-under-the-receiver operating characteristic curve for our method was significantly larger than that for Norén's methods regardless of simulation settings" /><sentence text=" The proposed method was also applied to the Food and Drug Administration Adverse Event Reporting System database, and a recognized drug-drug interaction was detected" /><sentence text="" /><sentence text="The proposed criterion controlled false positives at an acceptable level and had higher sensitivity than that of Norén's method had when events were rare" /><sentence text="" /></document>